Navigation Links
George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research
Date:12/6/2010

SAN ANTONIO George W. Sledge Jr., M.D., a nationally recognized pioneer in the development of novel therapies for breast cancer, will receive the 2010 William L. McGuire Memorial Lecture Award at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

Supported by GlaxoSmithKline Oncology (GSK) since its inception in 1992, this honor acknowledges distinguished internationally recognized researchers for their significant contributions to breast cancer research.

Sledge is the Ballve-Lantero Professor of Oncology and professor of medicine and pathology at the Indiana University School of Medicine, and a physician/ researcher at the Indiana University Melvin and Bren Simon Cancer Center. He is also co-director of the the IU Simon Cancer Center's breast program. Sledge specializes in the study and treatment of breast cancer, and his research specifically focuses on molecular and tumor biology, growth factors and anti-angiogenic therapy. He has chaired several nationwide clinical trials involving new therapies for breast cancer.

"Dr. Sledge's work developing novel therapies to treat women with breast cancer has improved the lives of countless cancer patients," said C. Kent Osborne, M.D., codirector of the San Antonio Breast Cancer Symposium and director of the Baylor College of Medicine Dan L. Duncan Cancer Center. "The selection of Dr. Sledge is even more appropriate since he was one of the first medical oncology fellows to graduate the new fellowship training program at the University of Texas Health Science Center Division of Medical Oncology, established by Dr. McGuire as division director in the late 1970s. We congratulate Dr. Sledge on this fitting honor."

Sledge will give a lecture entitled, "What Would Bill Do? Channeling Your Inner McGuire," on Saturday, Dec. 11, 2010, at 11:15 a.m. CT, during the 33rd Annual San Antonio Breast Cancer Symposium. This symposium, encompassing the full spectrum of breast cancer r
'/>"/>

Contact: Michele Sharp
michele.sharp@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
2. George M. Whitesides receives inaugural Dreyfus prize in the chemical sciences
3. American Society for Microbiology honors George Liu
4. Annual survey shows high numbers of seed scallops on Georges Bank, low numbers in Mid-Atlantic
5. George Whitesides accepts inaugural Dreyfus Prize in the Chemical Sciences
6. George Daley to discuss challenges and opportunities facing stem cell scientists
7. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
8. Little is understood about alcohols effect on fetal development, Georgetown researchers say
9. Chip Supply Hosts Visit by U.S. Senator George LeMieux
10. George Pólya Prize awarded to Emmanuel Candès and Terence Tao
11. Rensselaer Polytechnic Institute professor Georges Belfort wins biochemical engineering award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small ... Brands report showed that planet-wide, transactions at merchants on the ... the total number of credit, debit, and prepaid cards reached ... were victims of fraudulent card usage in 2012, and credit ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday Season may ... Acuity Market Intelligence reports that the long anticipated floodgates ... that intensifying demand for smart phones, tablets, and wearable ... market of 2.5 billion users with nearly 4.8 billion ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... production of a protein called vasostatin may prove a promising ... of print in Gut. , Pancreatic cancer is the fifth ... is extremely difficult to treat. Only 3% of affected patients ... that has remained static for the past three decades. , ...
... scientists for the first time has detected a memory ... a single, new stimulus. The research, done with honeybees ... living brain and explore short-term memory as never before, ... on the report who is currently a postdoctoral research ...
... among American men. It is estimated ... six males will develop the disease during his lifetime. However, promising new ... One of the most innovative of these treatments is robotic-assisted laparoscopic prostatectomy ... one of only ...
Cached Biology News:Gene therapy potential for treatment of pancreatic cancer 2Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace 2Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace 3Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 2Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer 3
(Date:1/22/2015)... Controlled Substance Compliance Services (CSCS), a project ... the legal requirements around using controlled substances in pharmaceutical ... As their international operations expand and become increasingly complex, ... as a result of the first phase of the ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
(Date:1/22/2015)... DIEGO , Jan. 22, 2015   Cypher ... and Sequenom, Inc. (NASDAQ: SQNM ), ... development agreement for next generation noninvasive prenatal tests ... genome interpretation technology, called Mantis™, to advance analysis ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4GenoSpace Expands Board with Appointment of Michelle Munson 2
... Jan. 9, 2012 diaDexus, Inc. (OTC Bulletin ... vitro diagnostic products addressing unmet needs in cardiovascular ... approximately $4.9 million, up 48% from the prior ... 2011 revenue to $16.4 million, up 39% over ...
...   Sigma-Aldrich Corporation (NASDAQ: ... announced it has signed an agreement to acquire BioReliance Holdings, ... Avista Capital Partners for $350 million in cash.  The acquisition ... is expected to close in the first quarter of 2012.  ...
... 2012  Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ), ... of drugs for the treatment of human viral diseases, ... clinical trial of IDX184, the Company,s lead product candidate ... IDX184, a pan-genotypic oral nucleotide polymerase inhibitor, has demonstrated ...
Cached Biology Technology:diaDexus, Inc. Pre-Announces 2011 Q4, YE Revenue and 2012 Guidance 2diaDexus, Inc. Pre-Announces 2011 Q4, YE Revenue and 2012 Guidance 3Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services 2Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services 3Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services 4Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184 2Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184 3Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184 4Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184 5
...
...
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
... is designed to deparaffinize and perform Heat ... paraffin-embedded tissue sections mounted on glass microscope ... paraffin at the high temperature used in ... of the paraffin by detergent. Formaldehyde fixation ...
Biology Products: